Fundz

Phlox Therapeutics raised €1.9M in a seed funding round led by ROM Utrecht Region to advance its RNA therapies for genetic laminopathies.

PRIVATENov 13, 2024

Amount Raised

€1.9 Million

Round Type

Seed

NaardenBiotechnologyHealth CareGeneticsTherapeutics

Investors

Amsterdam Umc Venture HoldingUtrecht Health Seed Fund (Uhsf)Dutch Research Council (Nwo)Hubrecht InstituteFirst FundROM Utrecht Region

Description

Naarden-based Phlox Therapeutics has raised €1.9M in funding to advance its RNA therapies for genetic laminopathies. The funding round includes ROM Utrecht Region and other existing investors, with additional non-dilutive investment from the Dutch Research Council.

Who else raised in Genetics and Therapeutics around the same time

Companies in the same sectors as Phlox Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Akamis Bio raised $60M (Series A) on December 17, 2024.
  • AusperBio raised $73M (Series B) on December 27, 2024.
  • Phio Pharmaceuticals raised $30K (Seed) on December 24, 2024.
  • GEMMABio raised $34M (Series A) on December 23, 2024.
  • Lipella Pharmaceuticals raised $2.6M (Seed) on December 23, 2024.
  • Phio Pharmaceuticals raised $55K (Seed) on December 20, 2024.

Who to call at Phlox Therapeutics, and when

A new round usually means Phlox Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Phlox Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Phlox Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Phlox Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Phlox Therapeutics

Location

Naarden, North Holland, Netherlands

About

Phlox Therapeutics is a biotechnology company founded in 2022 that specializes in developing RNA-based gene therapies to treat genetic laminopathies and cardiomyopathies. The company focuses on targeting genetic mutations associated with these conditions, aiming to improve patient outcomes. By advancing its RNA technology, Phlox aims to become a key player in next-generation RNA therapies for genetic heart diseases. Their work seeks to address currently untreatable genetic conditions and improve treatment options for patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Phlox Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Phlox Therapeutics's next move

See what Strategic adds

Phlox Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.